Vascular endothelial growth factor secretion and immunosuppression are distinct potency mechanisms of human bone marrow mesenchymal stromal cells

被引:1
|
作者
Faircloth, Tyler U. [1 ]
Temple, Sara [1 ]
Parr, Rhett N. [1 ]
Tucker, Anna B. [1 ]
Rajan, Devi [1 ]
Hematti, Peiman [2 ]
Kugathasan, Subra [3 ,4 ]
Chinnadurai, Raghavan [1 ]
机构
[1] Mercer Univ, Sch Med, Dept Biomed Sci, 250 E 66th St, Macon, GA 31404 USA
[2] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA
[3] Emory Univ, Sch Med, Div Pediat Gastroenterol, Dept Pediat, Atlanta, GA USA
[4] Childrens Healthcare Atlanta, Atlanta, GA USA
关键词
mesenchymal stromal/stem cells; secretome; angiogenic factors; immunosuppression; human large intestinal endothelial cells; vascular endothelial growth factor A; INFLAMMATORY-BOWEL-DISEASE; OXIDE SYNTHASE INHIBITOR; NITRIC-OXIDE; STEM-CELLS; CROHNS-DISEASE; INTERNATIONAL SOCIETY; ANGIOGENIC PROPERTIES; PERIANAL FISTULAS; INTERFERON-GAMMA; L-NMMA;
D O I
10.1093/stmcls/sxae040
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Mesenchymal stromal cells (MSCs) are investigated as cellular therapeutics for inflammatory bowel diseases and associated perianal fistula, although consistent efficacy remains a concern. Determining host factors that modulate MSCs' potency including their secretion of angiogenic and wound-healing factors, immunosuppression, and anti-inflammatory properties are important determinants of their functionality. We investigated the mechanisms that regulate the secretion of angiogenic and wound-healing factors and immune suppression of human bone marrow MSCs. Secretory analysis of MSCs focusing on 18 angiogenic and wound-healing secretory molecules identified the most abundancy of vascular endothelial growth factor A (VEGF-A). MSC viability and secretion of other angiogenic factors are not dependent on VEGF-A secretion which exclude the autocrine role of VEGF-A on MSC's fitness. However, the combination of inflammatory cytokines IFN gamma and TNF alpha reduces MSC's VEGF-A secretion. To identify the effect of intestinal microvasculature on MSCs' potency, coculture analysis was performed between human large intestine microvascular endothelial cells (HLMVECs) and human bone marrow-derived MSCs. HLMVECs do not attenuate MSCs' viability despite blocking their VEGF-A secretion. In addition, HLMVECs neither attenuate MSC's IFN gamma mediated upregulation of immunosuppressive enzyme indoleamine 2,3-dioxygenase nor abrogate suppression of T-cell proliferation despite the attenuation of VEGF-A secretion. We found that HLMVECs express copious amounts of endothelial nitric oxide synthase and mechanistic analysis showed that pharmacological blocking reverses HLMVEC-mediated attenuation of MSC's VEGF-A secretion. Together these results suggest that secretion of VEGF-A and immunosuppression are separable functions of MSCs which are regulated by distinct mechanisms in the host. Graphical Abstract
引用
收藏
页码:736 / 751
页数:16
相关论文
共 50 条
  • [21] Effects of interferon-γ on secretion of vascular endothelial growth factor by endometrial stromal cells
    Kawano, Y
    Matsui, N
    Kamihigashi, S
    Narahara, H
    Miyakawa, I
    AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2000, 43 (01): : 47 - 52
  • [22] Transforming growth factor-β boosts the functionality of human bone marrow-derived mesenchymal stromal cells
    Kale, Vaijayanti P.
    CELL BIOLOGY INTERNATIONAL, 2020, 44 (11) : 2293 - 2306
  • [23] Regulation of vascular endothelial growth factor secretion in human meningioma cells
    Tsai, JC
    Hsiao, YY
    Teng, LJ
    Shun, CT
    Chen, CT
    Goldman, CK
    Kao, MC
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 1999, 98 (02) : 111 - 117
  • [24] Vascular endothelial growth factor A contributes to glioma-induced migration of human marrow stromal cells (hMSC)
    Schichor, Christian
    Birnbaum, Tobias
    Etminan, Nima
    Schnell, Oliver
    Grau, Stefan
    Miebach, Sabine
    Aboody, Karen
    Padovan, Claudio
    Straube, Andreas
    Tonn, Jorg-Christian
    Goldbrunner, Roland
    EXPERIMENTAL NEUROLOGY, 2006, 199 (02) : 301 - 310
  • [25] Vascular endothelial growth factor a contributes to glioma-induced migration of human marrow stromal cells (HMSCS)
    Schichor, C.
    Etminan, N.
    Birnbaum, T.
    Schnell, O.
    Straube, A.
    Tonn, J.
    Goldbrunner, R.
    NEURO-ONCOLOGY, 2006, 8 (04) : 330 - 330
  • [26] Modulation of vascular endothelial growth factor expression in rat bone marrow stromal cells by growth and differentiation factor-5 and hypoxia.
    Sena, K.
    Sumner, D. R.
    Virdi, A. S.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S210 - S210
  • [27] Methodological considerations for the enrichment of bone marrow endothelial and mesenchymal stromal cells
    Dray, Evan L.
    Ousley, Carey G.
    McKim, Daniel B.
    MOLECULAR IMMUNOLOGY, 2021, 131 : 127 - 136
  • [28] Early Signaling by Vascular Endothelial Growth Factor and Placental Growth Factor in Human Bone Marrow-Derived Endothelial Cells Is Mediated by Superoxide
    Dhar-Mascareno, Manya
    Mascareno, Eduardo
    Golde, David W.
    JOURNAL OF VASCULAR RESEARCH, 2009, 46 (06) : 601 - 608
  • [29] Mesenchymal stromal cells regulate the cell mobility and the immune response during osteogenesis through secretion of vascular endothelial growth factor A
    Zhou, Yinghong
    Huang, Rong
    Fan, Wei
    Prasadam, Indira
    Crawford, Ross
    Xiao, Yin
    JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 2018, 12 (01) : E566 - E578
  • [30] Human mesenchymal stem cells from bone marrow express tumor endothelial and stromal markers
    Bagley, Rebecca G.
    Weber, William
    Rouleau, Cecile
    Yao, Min
    Honma, Nakayuki
    Kataoka, Shiro
    Ishida, Isao
    Roberts, Bruce L.
    Teicher, Beverly A.
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2009, 34 (03) : 619 - 627